Brookfield makes $14.8bn bid for remaining stake in GGP

By zaymalz malz
Share

US-based mall owner General Growth Properties (GGP) has revealed that it received a takeover bid from Brookfield Property Partners, the landholdings arm of Toronto’s Brookfield Asset Management, with the Canadian firm looking to expand its footprint in the real estate market.

The bid, totalling $14.8bn, is an attempt from Brookfield to acquire the entirety of GGP, a firm that it currently holds a 34% stake in.

See also:

“The Board has formed a special committee of its non-executive, independent directors which, in consultation with its financial and legal advisors, will carefully review and consider the Proposal and pursue the course of action that it believes is in the best interests of the Company’s stockholders,” GGP said in a statement.

The $14.8bn offer equates to $23 per share. This had represented a 21% premium on GGP’s original stock price, however, this has since narrowed to just 3.6%, with GGP’s stock having surged after Bloomfield reported that Brookfield was in preliminary talks with the mall owner.

GGP currently owns approximately 127 properties, mostly across the US, with its clients including automaker Tesla, jeweller Tiffany and retailer Macy’s.

The offer is part-cash, part-stock, and, if accepted, will see Brookfield acquiring the remaining 66% stake in GGP.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy